StockData
Actinium Pharmaceuticals, Inc. logo

Actinium Pharmaceuticals, Inc. (ATNM) stock

ATNMNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 10/3081% below fair value
$1.35−0.14 (-9.40%)

Close on Nov 17, 2026Market cap $42.45MP/E 3.8Yield –

Actinium Pharmaceuticals pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Actinium Pharmaceuticals's pe ratio was 4.4× on Nov 11, 2026.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20264.4×–

More Actinium Pharmaceuticals figures

See a number that looks wrong?